Merck & Co., Inc. (MRK)
110.10
-0.91
(-0.82%)
USD |
NYSE |
Jan 15, 11:10
Merck SG&A Expense (TTM): 10.70B for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Amgen, Inc. | 6.976B |
| Gilead Sciences, Inc. | 5.886B |
| Regeneron Pharmaceuticals, Inc. | 2.717B |
| Cidara Therapeutics, Inc. | 28.09M |
| Moderna, Inc. | 1.061B |